tiprankstipranks
Achilles Therapeutics Regains Nasdaq Compliance, Boosting Investor Confidence
PremiumCompany AnnouncementsAchilles Therapeutics Regains Nasdaq Compliance, Boosting Investor Confidence
2M ago
Achilles Therapeutics Reports Q3 2024 Financial Results
Premium
Company Announcements
Achilles Therapeutics Reports Q3 2024 Financial Results
2M ago
Achilles Therapeutics receives approval to transfer to Nasdaq Capital Market
Premium
The Fly
Achilles Therapeutics receives approval to transfer to Nasdaq Capital Market
3M ago
Achilles to end development of TIL-based cNeT therapy, conduct strategic review
PremiumThe FlyAchilles to end development of TIL-based cNeT therapy, conduct strategic review
5M ago
Achilles Therapeutics Excels in Q2 with Promising Trials
Premium
Company Announcements
Achilles Therapeutics Excels in Q2 with Promising Trials
6M ago
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
Premium
The Fly
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
6M ago
Achilles Therapeutics Addresses Nasdaq Notice
PremiumCompany AnnouncementsAchilles Therapeutics Addresses Nasdaq Notice
9M ago
Achilles Therapeutics: Promising Q1 2024 Results
Premium
Company Announcements
Achilles Therapeutics: Promising Q1 2024 Results
9M ago
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
Premium
The Fly
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100